Industry Outlook

The cell surface markers market is set to reach US$ 33,712.7 Mn by 2026 from US$ 16,586.7 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2018 to 2026. Technological advancements in the production of monoclonal antibodies and manufacturing of cell specific antibodies for disease diagnosis and prognosis are the major factors to drive the cell surface markers market.

Pharmaceutical companies are engaged in the production of staining dyes and reagents which are employed in determining specific cytological protocols propel the cell surface markers market growth. The limitations associated with cell surface markers market is the frequent occurrence of false positive results and suffer tremendous competition from new generation sequencing technique for drug discovery and disease diagnosis.

"Increasing demand of targeted drug delivery and stem cell research will have a positive impact on flow cytometers market"

Reagents and kits are currently dominating the cell surface markers market by type segment on account of its application in determining microscopic cellular functions. They are widely used in understanding the cell signaling pathways and pharmacodynamic activities taking place at the G-protein coupled receptors etc. The reagents and kits are used to decipher cellular activities by the antigen-antibody reaction such as agglutination reaction, precipitation reaction, complement fixation, enzyme linked immunosorbent assay (ELISA) and immunofluorescence. Flow cytometers widely employ the cell surface markers to identify the cell population of hematopoietic stem cells such as CD 19, 20, 4 and CD34+ in the biological sample to understand the cell migration in diabetes and cardiovascular disease.

"Increasing use of cell surface markers in developing monoclonal antibodies to treat chronic diseases will boost drug discovery segment"

Cell surface markers are proteins that are expressed on the cell surface, which are helpful in identifying the lineage and differentiation stage. In the present scenario cell surface markers find huge demand in drug discovery and development as they help in analyzing epigenetic modification, gene regulation and genotyping. Rising prevalence of chronic diseases and increasing public health awareness has resulted in the burgeoning requirement of cell surface markers in disease diagnosis.

"Development of immunoassays for the quantification of biological samples to drive the diagnostic laboratories market"

In the last two decades there has been tremendous technological advancement in the development of immunoassays for quantification of biological samples. Cell surface markers are widely employed by pathologist in performing clinical and forensic investigation which has a positive impact on the market growth of diagnostic laboratories. Cell surface markers are utilized by aspiring researchers in academia for understanding the disease etiology of chronic idiopathic diseases, and to develop novel medicines for their treatment.

"Increasing number of diagnostic laboratories to drive the cell surface markers market in Asia Pacific"

Rising incidence of chronic diseases and existence of well-developed healthcare infrastructure are responsible for the dominance of North America in cell surface markers market. Presence of market leaders such as Abbott Laboratories, Inc., and F.Hoffman La-Roche AG., determine the cell surface markers market in Europe. Asia Pacific will register impressive growth throughout the forecast period owing to the increasing number of diagnostic laboratories and enhanced government funding in establishing new research and academia centers.

Quantitative analysis was performed to determine the existing market trends prevalent in cell surface markers market. Competitive landscape is deciphered to get a gist of the technological advancement taking place in cell surface markers market. In the latest news development segment the importance has been given to highlight the major merger & acquisitions and other growth strategies adopted by major players. Different types of reagent and kits used in drug discovery and disease diagnosis are covered in the product portfolio segment. The major players in the cell surface markers market are Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., F.Hoffman La-Roche AG, Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation and Thermo Fischer Scientific, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Cell Surface Markers market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Cell Surface Markers market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Cell Surface Markers market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Cell Surface Markers market?
• Which is the largest regional market for Cell Surface Markers market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Cell Surface Markers market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Cell Surface Markers market worldwide?